Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis
Boneu, B.; Sie, P.; Caranobe, C.; Cassigneul, J.; Pascal, J.
Thrombosis and Haemostasis 47(1): 78
1982
ISSN/ISBN: 0340-6245 PMID: 7071809 Document Number: 191398
Document emailed within 1 workday
Related Documents
Prasa, D.; Svendsen, L.; Stürzebecher, J. 1997: The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation Thrombosis and Haemostasis 77(3): 498-503Brill-Edwards, P.; Van Ryn-McKenna, J.; Cai, L.; Ofosu, F.A.; Buchanan, M.R. 1992: Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy Thrombosis and Haemostasis 68(4): 424-427
Levitan, B.N.; Astakhin, A.V.; Chishieva, E.M.; Afanas'ev, S.S. 2004: Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis Voenno-Meditsinskii Zhurnal 325(2): 60
Rodríguez Cuartero, A.; Mora Guijosa, A.; Núñez Carril, J. 1991: Antithrombin IIi and liver cirrhosis Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 79(1): 21-23
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
D'Amore, V.; Maestri, G.; Prandi, G.C. 1985: Concentration-reinfusion methods in intractable ascites caused by liver cirrhosis. Importance of monitoring plasma renin activity and urinary sodium Minerva Dietologica E Gastroenterologica 31(2): 317-321
Poiarkov, A.A.; Timoshok, N.A.; Spivak, N.I.; Poiarkova, S.A. 2010: Thrombin inhibitors which display antibacterial activity Ukrains'kyi Biokhimichnyi Zhurnal 82(1): 123-129
Stürner, K.H.; Holzhüter, H.; Ochs, H.G.; Angelkort, B.; Muchietti, F.; Wenzel, E. 1973: Reliability of reptilase and thrombin coagulase coagulation times for measurement of antithrombin VI activity with reference to immunoelectrophoretic characteristics of various fibrinogen and fibrin fission products Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 1328-1330
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302
Raper, C.G.; Love, H. 1978: Heparin-neutralizing activity, total progressive antithrombin and ethanol gel test in acute chest pain Thrombosis and Haemostasis 40(2): 418-422
Gandossi, E.; Lunven, C.; Gauffeny, C.; Roome, N.O.; Berry, C.N. 1998: Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors Thrombosis and Haemostasis 80(5): 840-844
Kordich, L.; Sassetti, B.; Lago, O. 1984: Hemostasis in untreated acute leukemia. II. Natural inhibitors: biological and immunological activity. Immunologic variation of antithrombin IIi Sangre 29(2): 133-140
Kaneko, T.; Arima, R.; Arakawa, Y.; Aoki, M.; Fukuda, K.; Fukui, M.; Hirama, A.; Fujita, E.; Mii, A.; Utsumi, K.; Shimizu, A.; Iino, Y. 2011: Two cases of rapidly progressive nephritic syndrome complicated with alcoholic liver cirrhosis Nihon Jinzo Gakkai Shi 53(1): 60-67
Stopik, D.; Hampel, K.E.; Beger, H.G. 1978: Plasma histamine concentration and hemodynamic changes in liver cirrhosis Leber Magen Darm 8(2): 91-93
Piatkowska, M.; Kotschy, M.; Rość, D.; Wiśniewska, E.; Opoka, J. 1994: Plasma serine protease inhibitors in patients with liver cirrhosis Acta Haematologica Polonica 25(2): 145-149
Marciniak, E.; Gora-Maslak, G. 1984: The interaction of immobilized thrombin with human antithrombin IIi Thrombosis and Haemostasis 51(1): 27-31
Fota-Markowska, H.; Modrzewska, R.; Krzowska-Firych, J.; Lis-Tønder, J.; Borowicz, I. 2004: Concentration of prothrombin fragment 1 + 2 (f1 + 2) in patients with liver cirrhosis and chronic hepatitis C infection Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 59(2): 4-7
Rahelić, D.; Kujundzić, M.; Romić, Z.; Brkić, K.; Petrovecki, M. 2006: Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis Collegium Antropologicum 30(3): 523-528
Tripodi, A.; Krachmalnicoff, A.; Mannucci, P.M. 1986: Characterization of an abnormal antithrombin (Milano 2) with defective thrombin binding Thrombosis and Haemostasis 56(3): 349-352
Senent, M.; Bellart, J.; Zuazu-Jausoro, I.; Oliver, A.; Montserrat, I.; Ribera, L.; Tirado, I.; Cabero, L.; Fontcuberta, J. 1991: Markers of hypercoagulability during pregnancy: thrombin-antithrombin-IIi complexes and D dimer Sangre 36(1): 21-24